Household transmissibility and other characteristics of seasonal oseltamivir-resistant influenza a(H1N1) viruses, Germany, 2007-8

Eurosurveillance

Volumn 15, Issue 6, 2010, Pages 4-

  Buchholz, U ^a   Brockmann, S ^a,b,c   Duwe, S ^a   Schweiger, B ^a   Heiden, M an Der ^a   Reinhardt, B ^a   Buda, S ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

^b State Health Office LGA Baden Württemberg   (Germany)

^c EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR;

ADOLESCENT; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FLU LIKE SYNDROME; GERMANY; HOUSEHOLD; HUMAN; INFANT; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; MAJOR CLINICAL STUDY; MALE; OSELTAMIVIR RESISTANT INFLUENZA A(H1N1) VIRUS; OSELTAMIVIR SUSCEPTIBLE INFLUENZA A(H1N1) VIRUS; PNEUMONIA; RISK FACTOR; SEASONAL INFLUENZA; VIRUS TRANSMISSION;

EID: 77952486727     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Monto AS, McKimm-Breschkin JL, Macken C, Hampson AW, Hay A, Klimov A, et al. Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. Antimicrob Agents Chemother. 2006;50(7):2395-402.
2. Sheu TG, Deyde VM, Okomo-Adhiambo M, Garten RJ, Xu X, Bright RA, et al. Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008. Antimicrob Agents Chemother. 2008;52(9):3284-92.
3. Ward P, Small I, Smith J, Suter P, Dutkowski R. Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic. J Antimicrob Chemother. 2005;55 Suppl 1: i5-i21.
4. Kiso M, Mitamura K, Sakai-Tagawa Y, et al. Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet. 2004;364(9436):759-65.
5. Carr J, Ives J, Kelly L, Lambkin R, Oxford J, Mendel, et al. Influenza virus carrying neuraminidase with reduced sensitivity to oseltamivir carboxylate has altered properties in vitro and is compromised for infectivity and replicative ability in vivo. Antiviral Res. 2002;54(2):79-88.
6. Herlocher ML, Carr J, Ives J, Elias S, Truscon R, Roberts N, et al. Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets. Antiviral Res. 2002;54(2):99-111.
7. Ives JA, Carr JA, Mendel DB, et al. The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo. Antiviral Res. 2002;55(2):307-17.
8. Carr J, Roberts N, Herlocher L. (2002). Further study of the transmission in ferrets of influenza A/H1N1 virus carrying a H274Y neuraminidase mutation for Tamiflu®, oseltamivir phosphate; Roche Research Report 1008171.
9. Meijer A, Lackenby A, Hungnes O, Lina B, van der Werf S, Schweiger B. Oseltamivir-resistant influenza A (H1N1) virus, Europe, 2007-08 season. Emerg Infect Dis. 2009;15(4):552-60.
10. EISS. European Influenza Surveillance Scheme. EISS update from August 27, 2008.[Accessed on: Nov 24, 2008]. Later updates available from: http://webportal.ecdcdmz.europa.eu/en/activities/surveillance/EISN/Pages/home.aspx.
11. Besselaar TG, Naidoo D, Buys A, Gregory V, McAnerney J, Manamela JM, et al. Widespread oseltamivir resistance in influenza A viruses (H1N1), South Africa. Emerg Infect Dis. 2008;14(11):1809-10.
12. World Health Organization (WHO). [Internet]. Geneva; 2008. Influenza A/H1N1 virus resistance to oseltamivir - 2008 influenza season, southern hemisphere. [Accessed on: Dec 01, 2008]. Available from: www.who.int/csr/disease/influenza/H1N1200801013.pdf.
13. European Centre for Disease Prevention and Control (ECDC). [Internet]. Stockholm; 2009. Monitoring of influenza antiviral resistance in EU during the 2008-09 season. [Accessed on: Feb 20, 2009]. Available from: http://ecdc.europa.eu/en/Health_topics/influenza/antivirals.aspx.
14. Duwe S, Schweiger B. A new and rapid genotypic assay for the detection of neuraminidase inhibitor resistant influenza A viruses of subtype H1N1, H3N2, and H5N1. Journal of virological methods. 2008;153(2):134-41.
15. EISS. European Influenza Surveillance Scheme. EISS updates. [Accessed on: Dec 01, 2008]. Later updates available from: http://webportal.ecdcdmz.europa.eu/en/activities/surveillance/EISN/Pages/home.aspx.
16. van der Vries E, van den Berg B, Schutten M. Fatal oseltamivir-resistant influenza virus infection. N Engl J Med. 2008;359(10):1074-6.
17. Ciancio BC, Meerhoff TJ, Kramarz P, et al. Oseltamivir- resistant influenza A(H1N1) viruses detected in Europe during season 2007-8 had epidemiologic and clinical characteristics similar to co-circulating susceptible A(H1N1) viruses. Euro Surveill. 2009;14(46). pii= 19412. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19412.
18. Dharan NJ, Gubareva LV, Meyer JJ, Okomo-Adhiambo M, McClinton RC, Marshall SA et al. Infections with oseltamivir- resistant influenza A(H1N1) virus in the United States. JAMA. 2009;301(10):1034-41.
19. Hauge S, Dudman S, Borgen K, Lackenby A, Hungnes O. Oseltamivir-resistant influenza viruses A(H1N1), Norway, 2007-08. Emerg Infect Dis. 2009;15(2):155-62.
20. Kramarz P, Monnet D, Nicoll A, Yilmaz C, Ciancio B. Use of oseltamivir in 12 European countries between 2002 and 2007 - lack of association with the appearance of oseltamivir-resistant influenza A(H1N1) viruses. Euro Surveill. Feb 5 2009;14(5). pii=19112. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19112